Persistent and neuropathic pain occur frequently in rheumatoid arthritis, or RA, and tools that assess patient-reported outcomes can help clinicians determine the right care plan, according to the ...
Moderate to severe psoriatic arthritis (PsA) correlates with worse mental health and higher financial burden, impacting quality of life and health care utilization. Black participants reported higher ...
Pain improvement was associated with remission or low disease activity in patients undergoing treatment for rheumatoid arthritis, a study found. Researchers used data from the international RA-BE-REAL ...
Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...
Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...
MedPage Today on MSN
GLP-1 drugs pick up another win, this time in psoriatic arthritis
Adding tirzepatide to ixekizumab significantly improved primary and key secondary outcomes ...
Study findings suggest that ixekizumab provides balanced joint and skin improvements with comparable treatment persistence to other b/tsDMARDs in routine PsA care.
Objectives To determine the prevalence of depressive and anxiety symptoms among young people 7 years and 9 years after ...
DENVER — Adding the weight-loss drug tirzepatide to the biologic ixekizumab significantly improved joint and skin outcomes in ...
WEST PALM BEACH, Fla. — Patient-reported outcomes (PROs) define the issues that matter to the patient, but their potential in multiple sclerosis (MS) is likely to remain unfulfilled until barriers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results